MRP Under Process
Official PMBI MRP is being updated for catalog code 2103.
Locate Jan Aushadhi KendraClinical Overview
Diclofenac Sodium Suppositories (100mg) is a rectal formulation on the WHO Model List of Essential Medicines. Rectal absorption bypasses gastric mucosal contact, providing effective systemic anti-inflammatory and analgesic action. Indicated for post-operative orthopedic pain, severe arthritis flares, and acute pain in patients unable to take oral medication.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Administer rectally: 1 suppository (100 mg) inserted pointed end first at bedtime into the rectum after a bowel movement. Retain inside. Wash hands before and after use.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Local rectal irritation, burning sensation, tenesmus, mild abdominal cramps. Rare/Severe: Proctitis, rectal bleeding, and systemic NSAID ulceration/cardiovascular risks.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
For rectal use only. Contraindicated in proctitis, active rectal bleeding, or history of peptic ulceration. Maximum daily dose from all routes (oral + rectal) must not exceed 150 mg.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or analgesic treatment guidance. Always consult a registered physician or orthopedic specialist before taking pain relievers, anti-inflammatory medications, or anti-arthritic therapies.